Literature DB >> 24876455

Real-world assessment of glycemic control after V-Go® initiation in an endocrine practice in the southeastern United States.

Barry R Johns1, Thomas C Jones1, John H Sink2, Catherine E Cooke3.   

Abstract

Keywords:  diabetes mellitus; glycated hemoglobin; insulin delivery; real-world assessment; retrospective review

Mesh：

Substances：

Year:  2014        PMID： 24876455      PMCID： PMC4455367          DOI： 10.1177/1932296814537041

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  5 in total

1.  Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

Review 2.  Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.

Authors:  D Pitocco; A Rizzi; G Scavone; L Tanese; F Zaccardi; A Manto; G Ghirlanda
Journal:  Minerva Endocrinol       Date:  2013-09       Impact factor: 2.184

Review 3.  Intensifying insulin therapy: what options are available to patients with type 2 diabetes?

Authors:  Luigi F Meneghini
Journal:  Am J Med       Date:  2013-09       Impact factor: 4.965

4.  TheV-Go insulin delivery device used in clinical practice: patient perception and retrospective analysis of glycemic control.

Authors:  Cheryl R Rosenfeld; Nancy J Bohannon; Bruce Bode; Adam S Kelman; Shari N Mintz; Alan B Schorr; Marc I Sandberg; Sridhar Nambi; Sumon K Agarwala; Steven B Leichter; Bart Larrabee; Lei Shi; Poul Strange
Journal:  Endocr Pract       Date:  2012 Sep-Oct       Impact factor: 3.443

Review 5.  Empowering people with diabetes: improving perceptions and outcomes with technical advances in insulin pens.

Authors:  David Oyer; Marcus Niemeyer; Alan Moses
Journal:  Postgrad Med       Date:  2012-09       Impact factor: 3.840
  5 in total
  9 in total

1.  Where to Go Now With V-Go?

Authors:  Bithika M Thompson; Curtiss B Cook
Journal:  J Diabetes Sci Technol       Date:  2015-06-15

2.  Evaluation of Clinical Outcomes With the V-Go Wearable Insulin Delivery Device in Patients With Type 2 Diabetes.

Authors:  Lisa T Meade; Dawn Battise
Journal:  Clin Diabetes       Date:  2021-07

3.  A Pragmatic Clinical Trial to Compare the Real-World Effectiveness of V-Go versus Standard Delivery of Insulin in Patients with Advanced Type 2 Diabetes.

Authors:  Mark J Cziraky; Scott Abbott; Matt Nguyen; Kay Larholt; Elizabeth Apgar; Thomas Wasser; Poul Strange; Leon Shi; H Courtenay Harrison; Beverly Everitt; Lynn Nowak
Journal:  J Health Econ Outcomes Res       Date:  2019-03-27

4.  Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis.

Authors:  Ripu Hundal; Stephan Kowalyk; Amanda Wakim; Carla Nikkel; John H Sink Ii; Melissa Doyle
Journal:  Med Devices (Auckl)       Date:  2020-09-22

5.  Use of V-Go® Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System.

Authors:  Rosemarie Lajara; Dianne A Fetchick; Tracy L Morris; Carla Nikkel
Journal:  Diabetes Ther       Date:  2015-10-15       Impact factor: 2.945

6.  The Clinical and Economic Impact of the V-Go® Disposable Insulin Delivery Device for Insulin Delivery in Patients with Poorly Controlled Diabetes at High Risk.

Authors:  Rosemarie Lajara; Carla Nikkel; Scott Abbott
Journal:  Drugs Real World Outcomes       Date:  2016-06-02

Review 7.  Recent Progress in Nanobiosensors for Precise Detection of Blood Glucose Level.

Authors:  Haniye Khosravi Ardakani; Mitra Gerami; Mostafa Chashmpoosh; Navid Omidifar; Ahmad Gholami
Journal:  Biochem Res Int       Date:  2022-01-17

8.  Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis.

Authors:  David Sutton; Charissa D Higdon; Carla Nikkel; Karrie A Hilsinger
Journal:  Adv Ther       Date:  2018-05-10       Impact factor: 3.845

9.  Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes.

Authors:  Pablo F Mora; David R Sutton; Ashwini Gore; Bantwal Baliga; Rebecca F Goldfaden; Carla Nikkel; John Sink Ii; Beverley Adams-Huet
Journal:  BMJ Open Diabetes Res Care       Date:  2020-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.